Mechanism of Action
12.1 Mechanism of Action The mechanism of action of ZYCLARA in the treatment of AK and EGW is unknown. 12.2 Pharmacodynamics The pharmacodynamics of ZYCLARA are unknown. Imiquimod is a Toll-like receptor 7 agonist that activates immune cells. Topical application to skin is associated with increases…
Clinical Trials (5)
Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma
Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma
Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix
Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream
Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis